Clearance of measles virus from persistently infected cells by short hairpin RNA

Journal of Virology

Volumn 83, Issue 18, 2009, Pages 9423-9431

  Zinke, Michael ^a   Kendl, Sabine ^a   Singethan, Katrin ^a   Fehrholz, Markus ^a   Reuter, Dajana ^a   Rennick, Linda ^b   Herold, Marco J ^c   Schneider Schaulies, Jürgen ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; ENHANCED GREEN FLUORESCENT PROTEIN; GLYCINE DEHYDROGENASE (DECARBOXYLATING); GUANINE NUCLEOTIDE BINDING PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEASLES VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RNA SEQUENCE; VERO CELL; VIRUS GENE;

CELL LINE, TUMOR; GENES, REPORTER; GENETIC VECTORS; HUMANS; LENTIVIRUS; MEASLES; MEASLES VIRUS; RNA, SMALL INTERFERING; RNA, VIRAL; TRANSDUCTION, GENETIC;

MEASLES VIRUS;

EID: 69449102362     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00846-09     Document Type: Article

References (41)

1. Allen, I. V., S. McQuaid, J. McMahon, J. Kirk, and R. McConnell. 1996. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J. Neuropathol. Exp. Neurol. 55:471-480.
2. Baczko, K., M. Carter, M. A. Billeter, and V. ter Meulen. 1984. Measles virus gene expression in subacute sclerosing panencephalitis. Virus Res. 1:585-595.
3. Baczko, K., U. G. Liebert, M. A. Billeter, R. Cattaneo, H. Budka, and V. ter Meulen. 1986. Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J. Virol. 59:472-478.
4. Bellini, W. J., J. S. Rota, L. E. Lowe, R. S. Katz, P. R. Dyken, S. R. Zaki, W.-J. Shieh, and P. A. Rota. 2005. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than previously recognized. J. Infect. Dis. 192:1686-1693.
5. Boden, D., O. Pusch, R. Silbermann, F. Lee, L. Tucker, and B. Ramratnam. 2004. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res. 32:1154-1158. (Pubitemid 38854717)
6. Caplen, N. J. 2003. RNAi as a gene therapy approach. Expert Opin. Biol. Ther. 3:575-586.
7. Cathomen, T., B. Mrkic, D. Spehner, R. Drillien, R. Naef, J. Pavlovic, A. Aguzzi, M. A. Billeter, and R. Cattaneo. 1998. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17:3899-3908. (Pubitemid 28333976)
8. Cathomen, T., H. Y. Naim, and R. Cattaneo. 1998. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72:1224-1234. (Pubitemid 28116907)
9. Cattaneo, R., G. Rebmann, A. Schmid, K. Baczko, V. ter Meulen, and M. A. Billeter. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:681-687.
10. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
11. Consiglio, A., A. Gritti, D. Dolcetta, A. Follenzi, C. Bordignon, F. H. Gage, A. L. Vescovi, and L. Naldini. 2004. Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101:14835-14840.
12. Das, A. T., T. R. Brummelkamp, E. M. Westerhout, M. Vink, M. Madiredjo, and R. Bernards. 2004. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78:2601-2605. (Pubitemid 38228957)
13. Dörries, R., and V. ter Meulen. 1984. Detection and identification of virus specific oligoclonal IgG in unconcentrated cerebrospinal fluid by immunoblot technique. J. Neuroimmunol. 7:77-89.
14. Dull, T., R. Zufferey, M. Kelly, R. J. Mandel, M. Nguyen, D. Trono, and L. Naldini. 1998. A third generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471. (Pubitemid 28471781)
15. Duprex, W. P., I. Duffy, S. McQuaid, L. Hamill, J. Schneider-Schaulies, L. Cosby, M. Billeter, V. ter Meulen, and B. Rima. 1999. The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J. Virol. 73:6916-6922.
16. Esiri, M. M., D. R. Oppenheimer, B. Brownell, and M. Haire. 1981. Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J. Neurol. Sci. 53:29-43.
17. Fujinami, R. S., and M. B. A. Oldstone. 1979. Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279:529-530.
18. Gitlin, L., J. K. Stone, and R. Andino. 2005. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79:1027-1035. (Pubitemid 40053886)
19. Hughes, S. M., F. Moussavi-Harami, S. L. Sauter, and B. L. Davidson. 2002. Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol. Ther. 5:16-24.
20. Keita, D., R. Servan de Almeida, G. Libeau, and E. Albina. 2008. Identification and mapping of a region on the mRNA of Morbillivirus nucleoprotein susceptible to RNA interference. Antivir. Res. 80:158-167.
21. Kumar, P., H. Wu, J. L. McBride, K. E. Jung, M. H. Kim, B. L. Davidson, S. K. Lee, P. Shankar, and N. Manjunath. 2007. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39-43. (Pubitemid 47037001)
22. Liebert, U. G., and D. Finke. 1995. Measles infections in rodents. Curr. Top. Microbiol. Immunol. 191:149-166.
23. Lois, C., E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872. (Pubitemid 34118370)
24. Lopez-Fraga, M., N. Wright, and A. Jimenez. 2008. RNA interference-based therapeutics: new strategies to fight infectious disease. Infect. Disord. Drug Targets 8:262-273.
25. Ludlow, M., S. McQuaid, S. L. Cosby, R. Cattaneo, B. K. Rima, and W. P. Duprex. 2005. Measles virus superinfection immunity and receptor redistribution in persistently infected NT2 cells. J. Gen. Virol. 86:2291-2303.
26. Mehta, P. D., J. Kulczycki, S. P. Mehta, W. Sobczyk, P. K. Coyle, E. A. Sersen, and H. M. Wisniewski. 1992. Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis. Clin. Immunol. Immunopathol. 65:53-59.
27. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
28. Otaki, M., D. P. Jiang, M. Sasayama, M. Nagano-Fujii, and H. Hotta. 2007. Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus. Microbiol. Immunol. 51:985-991.
29. Otaki, M., K. Sada, H. Kadoya, M. Nagano-Fujii, and H. Hotta. 2006. Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference. Antivir. Res. 70:105-111.
30. Pleasure, S. J., and V. M. Lee. 1993. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:585-602.
31. Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, M. Huber, C. Dötsch, G. Christiansen, and M. A. Billeter. 1995. Rescue of measles virus from cloned DNA. EMBO J. 14:5773-5784.
32. Reuter, T., B. Weissbrich, S. Schneider-Schaulies, and J. Schneider-Schaulies. 2006. RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J. Virol. 80:5951-5957. (Pubitemid 43849172)
33. Richardson, C. D., and P. W. Choppin. 1983. Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology 131:518-532.
34. Rima, B. K., J. A. P. Earle, K. Baczko, V. ter Meulen, J. Carabana, M. Caballero, M. L. Celma, and R. Fernandez-Munoz. 1997. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 78:97-106.
35. Rubinson, D. G., C. P. Dillon, A. V. Kwiatkowski, C. Sievers, L. Yang, J. Kopinja, M. Zhang, M. T. McManus, F. B. Gertler, M. L. Scott, and L. van Parijs. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:401-406.
36. Schneider-Schaulies, J., S. Schneider-Schaulies, and V. Ter Meulen. 1993. Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology 195:219-228. (Pubitemid 23210001)
37. Schubert, S., K. Möller-Ehrlich, K. Singethan, S. Wiese, W. P. Duprex, B. K. Rima, S. Niewiesk, and J. Schneider-Schaulies. 2006. A mouse model of persistent brain infection with recombinant measles virus. J. Gen. Virol. 87:2011-2019.
38. Suryanarayana, K., K. Baczko, V. ter Meulen, and R. R. Wagner. 1994. Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J. Virol. 68:1532-1543.
39. Takasu, T., J. M. Mgone, C. S. Mgone, K. Miki, K. Komase, H. Namae, Y. Saito, Y. Kokubun, T. Nishimura, R. Kawanishi, T. Mizutani, T. J. Markus, J. Kono, P. G. Asuo, and M. P. Alpers. 2003. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the eastern highlands of Papua New Guinea. Epidemiol. Infect. 131:887-898.
40. ter Meulen, V., S. Loffler, M. J. Carter, and J. R. Stephenson. 1981. Antigenic characterization of measles and SSPE virus haemagglutinin by monoclonal antibodies. J. Gen. Virol. 57:357-364.
41. Weissbrich, B., J. Schneider-Schaulies, and V. ter Meulen. 2003. Measles and its neurological complications. Marcel Dekker, New York, NY.